A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ezetimibe Impurity 63 - Request Quote

Picture of Ezetimibe Impurity 63

Ezetimibe Impurity 63

SZ CAT No:SZ-E026135
CAS No
NA
Mol.F.
C30H39F2NO4Si2
Mol.Wt.
571.8
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ezetimibe Impurity 63 is chemically (2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoic acid. Ezetimibe Impurity 63 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 63 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ezetimibe Impurity 63

Purchase Ezetimibe Impurity 63

Ezetimibe Impurity 63 suppliers

Ezetimibe Impurity 63 manufacturers

Ezetimibe Impurity 63 price

Order Ezetimibe Impurity 63

Enquire Ezetimibe Impurity 63

Ezetimibe Impurity 63 cost

Ezetimibe Impurity 63 Supplier

Ezetimibe Impurity 63 Distributor

Ezetimibe Impurity 63 for Method Validation

Ezetimibe Reference Standard

Ezetimibe Impurity 63 for ANDA Filing

Ezetimibe Impurity 63 for Forced Degradation Studies

Ezetimibe Impurity 63 Identification Standards

Ezetimibe Impurity 63 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,